that need to be taken into considerations to ensure the clinical trials are successful. Concerns such as qualified data and limited number of trained operational team, have deterred pharmaceuticals ... ensuring trial…
chronic urticaria. Clinical trials have shown that rupatadine, which shows a rapid onset of action and prolonged duration of activity, is effective and well tolerated. Safety data indicate that rupatadine
safety of fixed-dose LABA/LAMAs glycopyrronium/indacaterol (QVA149) and umeclidinium/vilanterol. Considerable clinical trial data are available demonstrating improvements in lung function and patient-reported outcomes…
inhibitors currently in clinical trials. This manuscript provides an overview of the c-MET signaling pathway, including its role in the development of cancers, and presents data that support this
hypocretin receptors for the treatment of sleep disorders such as insomnia. Preclinical and limited clinical data on hypocretin antagonists have shown favorable outcomes in the treatment of insomnia but concerns
modulating the host immune response in graft versus host or autoimmune diseases. The clinical applications of MSCs for rheumatic diseases are limited and address primarily their potential to help tissue ... MSCs might…
This article briefly reviews the profile of g-secretase inhibitors that have reached the clinic. Studies in both transgenic and nontransgenic animal models of AD have indicated that g-secretase ... administered by the…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.